In this special edition of PharmaVentures Insights, we explore the challenges faced by pharmaceutical companies during the manufacturing divestment process, and how to accelerate the divestment process to achieve a successful outcome.

Paul Larsmon spoke with leading experts including:

  • Mark Bamforth, President and CEO, Arranta Bio
  • Stéphane Lepeu, Directeur Général Délégué / Chief Commercial Officer, DELPHARM
  • Jansen Jacob, Vice President, PharmaVentures